Allogeneic Stem Cell Transplantation (SCT) After Dose-Reduced Conditioning for Myelofibrosis Patients

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2008 by Universitätsklinikum Hamburg-Eppendorf.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by:

Universitätsklinikum Hamburg-Eppendorf

ClinicalTrials.gov Identifier:

NCT00599547

First received: January 11, 2008

Last updated: October 21, 2008

Last verified: October 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	June 2010
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

No publications provided by Universitätsklinikum Hamburg-Eppendorf

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kröger N, Holler E, Kobbe G, Bornhäuser M, Schwerdtfeger R, Baurmann H, Nagler A, Bethge W, Stelljes M, Uharek L, Wandt H, Burchert A, Corradini P, Schubert J, Kaufmann M, Dreger P, Wulf GG, Einsele H, Zabelina T, Kvasnicka HM, Thiele J, Brand R, Zander AR, Niederwieser D, de Witte TM. Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2009 Dec 17;114(26):5264-70. Epub 2009 Oct 7.

To Top